Why This Matters: Canada already makes patients wait too long for new medicines. Global drug policy changes could make things worse.
Canadians already have the longest wait in the G7 to access new medicines, with only a small share of globally available drugs reaching public drug plans. As global pricing changes create new uncertainty, Canada will need meaningful market reforms to ensure patients can access the medicines they need, when they need them.